Research programme: Campylobacter jejuni/Escherichia coli Vaccines - TD Vaccines

Drug Profile

Research programme: Campylobacter jejuni/Escherichia coli Vaccines - TD Vaccines

Alternative Names: ACE 920

Latest Information Update: 29 Nov 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ACE BioSciences
  • Developer TD Vaccines A/S; Zymenex A/S
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Traveller's diarrhoea

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Traveller's-diarrhoea(Prevention) in Netherlands (PO)
  • 09 Nov 2009 Preclinical trials in Traveller's diarrhoea in Netherlands (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top